20(R)-Ginsenoside Rg2
Cat. No.：YN482757
CAS No. ：80952-72-3
| 产品名称: | 20(R)-Ginsenoside Rg2 |
| CAS No.: | 80952-72-3 |
| Chemical Name: | (3β,6α,12β,20R)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside; GF VII; Notoginsenoside Rg2; R-Ginsenoside Rg2; |
| Synonyms: | 20(R)-人参皂苷 Rg2 |
| 分子量: | 785.01 |
| 分子式: | C₄₂H₇₂O₁₃ |
| SMILES: | C[C@]12[C@@]3(C)[C@]([C@](CC[C@H](O)C4(C)C)(C)[C@@]4([H])[C@@H](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)C3)([H])C[C@@H](O)[C@]1([H])[C@]([C@@](CC/C=C(C)/C)(O)C)([H])CC2 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | 20(R)-Ginsenoside Rg2 是从人参茎和叶中分离得到的一种人参皂苷。20(R)-Ginsenoside Rg2 对肺癌 NCI-H1650 细胞具有抑制作用。具有抗癌活性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Ma, L., et al.: Molecules, 21, 757/1-757/15 (2016)
Kim, D., et al.: Tox. Lett., 259, 1-10 (2016)
